OCC Enhances Operational Efficiency with AWS GenAI Solutions Intellia Therapeutics Announces Presentations at the 24th American Society of Gene and Cell Therapy Annual Meeting
– Updated preclinical data will be presented on CRISPR/Cas9-mediated targeted gene insertion to treat alpha-1…
New Preclinical Data from Dyne Therapeutics’ Myotonic Dystrophy Type 1 Program to be Featured in Presentations During Upcoming American Society of Gene & Cell Therapy Annual Meeting
Company to host webcast including leading DM1 expert, Dr. Charles Thornton, following presentations on May…
Freeline to Present Data at the American Society of Gene and Cell Therapy Annual Meeting 2021
LONDON, April 27, 2021 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company”…
4D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT and ATS Annual Meetings on Three Wholly-Owned Product Candidates from Non-Human Primate Studies
– Abstracts on 4D-150 for wet AMD/DME and 4D-310 for Fabry disease accepted for oral presentations…
Akouos to Present Nonclinical Data from AK-OTOF and AK-antiVEGF Programs at the American Society of Gene and Cell Therapy 24th Annual Meeting
BOSTON, April 27, 2021 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine…
Travere Therapeutics to Present at the BofA Securities 2021 Virtual Health Care Conference
SAN DIEGO, April 27, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Adaptimmune to Present First Preclinical Data from its HLA-independent TCR (HiT) Platform at ASGCT
PHILADELPHIA and OXFORDSHIRE, United Kingdom, April 27, 2021 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq:ADAP),…
Codiak to Present Preclinical Data Demonstrating Broad Potential Applications for Engineered Exosomes at the American Society for Gene and Cell Therapy (ASGCT) Annual Meeting
– engEx™ Platform and in vitro and in vivo findings support utility across multiple therapeutic…
Sigilon Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 24th Annual Meeting
Presentations include initial results from preclinical studies of expanded pipeline programs in immune-mediated and metabolic…
Affinia Therapeutics to Present New Data and Updates on AAV Platform at the American Society of Gene and Cell Therapy Annual Meeting
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) — Affinia Therapeutics, an innovative gene therapy company…
Pacific Biosciences Nominates Dr. Hannah Valantine to its Board of Directors
MENLO PARK, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:…
Orphazyme to present at upcoming investor conferences
Orphazyme A/SInvestor news No. 05/2021Company Registration No. 32266355 Copenhagen, Denmark and Chicago, IL, USA, April 27, 2021…
Athenex to Provide Corporate and Financial Update for the First Quarter 2021 on May 6, 2021
BUFFALO, N.Y., April 27, 2021 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
Adaptive Biotechnologies to Present at the BofA Securities 2021 Virtual Healthcare Conference
SEATTLE, April 27, 2021 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial stage…
Tarsus Pharmaceuticals, Inc. to Present at the BofA Securities 2021 Virtual Health Care Conference
IRVINE, Calif., April 27, 2021 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a late…
Myriad Genetics to Release March 2021 Quarterly Financial Results on May 3, 2021, Host Investor Day on May 4, 2021
SALT LAKE CITY, April 27, 2021 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a…
BioVie Acquires Biopharma Assets from Privately Held NeurMedix
Includes Pivotal Phase 3 Alzheimer’s Asset NE3107 Cuong V. Do Named CEO of The New…
Leading BioSciences Closes Merger with Seneca Biopharma and Set to Begin Trading on Nasdaq as PALI
The combined company, Palisade Bio, Inc., is expected to commence trading on the Nasdaq Capital…
Gain Therapeutics to Present at the B. Riley Securities’ Virtual Neuroscience Conference
BETHESDA, Md., April 27, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (NASDAQ: GANX) (“Gain”) a…
Y-mAbs Submits Omburtamab Marketing Authorization Application to the European Medicines Agency
NEW YORK, April 27, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq:…